John C.S. Breitner

36.8k total citations · 6 hit papers
279 papers, 21.2k citations indexed

About

John C.S. Breitner is a scholar working on Psychiatry and Mental health, Physiology and Neurology. According to data from OpenAlex, John C.S. Breitner has authored 279 papers receiving a total of 21.2k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Psychiatry and Mental health, 126 papers in Physiology and 37 papers in Neurology. Recurrent topics in John C.S. Breitner's work include Dementia and Cognitive Impairment Research (127 papers), Alzheimer's disease research and treatments (120 papers) and Tryptophan and brain disorders (21 papers). John C.S. Breitner is often cited by papers focused on Dementia and Cognitive Impairment Research (127 papers), Alzheimer's disease research and treatments (120 papers) and Tryptophan and brain disorders (21 papers). John C.S. Breitner collaborates with scholars based in United States, Canada and Sweden. John C.S. Breitner's co-authors include Maria C. Norton, David C. Steffens, Peter P. Zandi, Kathleen A. Welsh‐Bohmer, Constantine G. Lyketsos, Constantine G. Lyketsos, Annette L. Fitzpatrick, Oscar L. López, Beverly N. Jones and Brenda L. Plassman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

John C.S. Breitner

272 papers receiving 20.5k citations

Hit Papers

Prevalence of Neuropsychiatric Symptoms in Dementia and M... 2000 2026 2008 2017 2002 2000 2007 2000 2004 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
    2002 1.6k citations Constantine G. Lyketsos, Oscar L. López et al. profile →
  2. Mental and Behavioral Disturbances in Dementia: Findings From the Cache County Study on Memory in Aging
    2000 886 citations Constantine G. Lyketsos, JoAnn T. Tschanz et al. profile →
  3. Intranasal insulin improves cognition and modulates β-amyloid in early AD
    2007 660 citations John C.S. Breitner et al. Neurology profile →
  4. Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias
    2000 640 citations Brenda L. Plassman, Richard J. Havlik et al. Neurology profile →
  5. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.
    2004 542 citations Peter P. Zandi, Maria C. Norton et al. PubMed profile →
  6. Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
    2007 530 citations Peter P. Zandi, Constantine G. Lyketsos et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John C.S. Breitner United States 78 9.4k 8.1k 3.3k 2.4k 2.0k 279 21.2k
Walter A. Kukull United States 74 10.0k 1.1× 8.4k 1.0× 2.5k 0.8× 2.6k 1.1× 975 0.5× 252 21.1k
Miia Kivipelto Sweden 80 9.8k 1.0× 10.2k 1.2× 3.3k 1.0× 3.2k 1.3× 1.8k 0.9× 434 26.7k
Frederick A. Schmitt United States 66 6.8k 0.7× 7.7k 0.9× 3.1k 0.9× 2.4k 1.0× 1.9k 1.0× 273 18.0k
Nathan Herrmann Canada 67 7.7k 0.8× 3.8k 0.5× 3.0k 0.9× 1.7k 0.7× 2.3k 1.2× 465 22.4k
Oscar L. López United States 81 13.3k 1.4× 9.2k 1.1× 3.8k 1.2× 2.1k 0.8× 1.5k 0.8× 466 27.1k
Ronald G. Thomas United States 60 5.6k 0.6× 7.7k 1.0× 2.1k 0.6× 2.7k 1.1× 3.0k 1.5× 179 18.7k
Denis A. Evans United States 83 8.9k 0.9× 8.6k 1.1× 2.2k 0.7× 2.4k 1.0× 1.4k 0.7× 248 29.0k
David Ames Australia 67 8.6k 0.9× 7.5k 0.9× 1.9k 0.6× 2.0k 0.8× 1.4k 0.7× 389 18.3k
‌Barry Reisberg United States 64 12.2k 1.3× 6.5k 0.8× 2.7k 0.8× 1.6k 0.6× 1.9k 1.0× 209 21.3k
Rachelle S. Doody United States 55 10.2k 1.1× 8.5k 1.0× 3.2k 1.0× 2.6k 1.1× 4.3k 2.2× 243 21.3k

Countries citing papers authored by John C.S. Breitner

Since Specialization
Citations

This map shows the geographic impact of John C.S. Breitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C.S. Breitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C.S. Breitner more than expected).

Fields of papers citing papers by John C.S. Breitner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C.S. Breitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C.S. Breitner. The network helps show where John C.S. Breitner may publish in the future.

Co-authorship network of co-authors of John C.S. Breitner

This figure shows the co-authorship network connecting the top 25 collaborators of John C.S. Breitner. A scholar is included among the top collaborators of John C.S. Breitner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C.S. Breitner. John C.S. Breitner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Raihaan, Alyssa Salaciak, Saashi A. Bedford, et al.. (2025). Exploring morphological and microstructural signatures across the Alzheimer's spectrum and risk factors. Neurobiology of Aging. 149. 1–18.
2.
Picard, Cynthia, Anne Labonté, Erlan Sanchez, et al.. (2024). Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 16(1). e12521–e12521. 7 indexed citations
3.
Iturria‐Medina, Yasser, Simon Ducharme, Pedro Rosa‐Neto, et al.. (2022). Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneity. Science Advances. 8(46). eabo6764–eabo6764. 43 indexed citations
4.
Tam, Angela, Christian Dansereau, Yasser Iturria‐Medina, et al.. (2019). A highly predictive signature of cognition and brain atrophy for progression to Alzheimer's dementia. GigaScience. 8(5). 19 indexed citations
5.
Kulic, Luka, Charlotte E. Teunissen, Adeola Shobo, et al.. (2019). Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression. Nature Communications. 10(1). 2240–2240. 47 indexed citations
6.
Maysinger, Dušica, Alexandre Moquin, Shireen Hossain, et al.. (2017). Dendritic Polyglycerol Sulfates in the Prevention of Synaptic Loss and Mechanism of Action on Glia. ACS Chemical Neuroscience. 9(2). 260–271. 31 indexed citations
7.
Tam, Angela, Christian Dansereau, AmanPreet Badhwar, et al.. (2016). A dataset of multiresolution functional brain parcellations in an elderly population with no or mild cognitive impairment. Data in Brief. 9. 1122–1129. 1 indexed citations
8.
Peterson, David B., Chris Corcoran, Carlos Cruchaga, et al.. (2013). Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: The Cache County Dementia Progression Study. Alzheimer s & Dementia. 10(3). 366–371. 28 indexed citations
9.
Carlson, Michelle C., Chris Corcoran, Maria C. Norton, et al.. (2011). Cognitive Stimulation and Cognitive and Functional Decline in Alzheimer's Disease: The Cache County Dementia Progression Study. The Journals of Gerontology Series B. 66B(4). 416–425. 53 indexed citations
10.
Breitner, John C.S.. (2009). S4‐02‐03: Treatment effects of NSAIDs related to stage of Alzheimer pathogenesis: Lessons from ADAPT. Alzheimer s & Dementia. 5(4S_Part_5). 1 indexed citations
11.
Norton, Maria C., Devinder Kaur Ajit Singh, Ingmar Skoog, et al.. (2008). Church Attendance and New Episodes of Major Depression in a Community Study of Older Adults: The Cache County Study. The Journals of Gerontology Series B. 63(3). P129–P137. 32 indexed citations
12.
Szekely, Christine A., John C.S. Breitner, Annette L. Fitzpatrick, et al.. (2007). NSAID use and dementia risk in the Cardiovascular Health Study*. Neurology. 70(1). 17–24. 149 indexed citations
13.
Wengreen, Heidi J., Ron Munger, Chris D. Corcoran, et al.. (2007). Antioxidant intake and cognitive function of elderly men and women: the Cache County Study.. PubMed. 11(3). 230–7. 97 indexed citations
14.
Plassman, Brenda L., David C. Steffens, James R. Burke, et al.. (2006). Duke Twins Study of Memory in Aging in the NAS-NRC Twin Registry. Twin Research and Human Genetics. 9(6). 950–957. 24 indexed citations
15.
Norton, Maria C., Ingmar Skoog, Christopher Corcoran, et al.. (2006). Gender Differences in the Association Between Religious Involvement and Depression: The Cache County (Utah) Study. The Journals of Gerontology Series B. 61(3). P129–P136. 45 indexed citations
16.
López, Oscar L., William J. Jagust, Corinne Dulberg, et al.. (2003). Risk Factors for Mild Cognitive Impairment in the Cardiovascular Health Study Cognition Study. Archives of Neurology. 60(10). 1394–1394. 372 indexed citations
17.
Holsinger, Tracey, David C. Steffens, Caroline Phillips, et al.. (2002). Head Injury in Early Adulthood and the Lifetime Risk of Depression. Archives of General Psychiatry. 59(1). 17–17. 209 indexed citations
18.
Steffens, David C., Kathleen A. Welsh, James R. Burke, et al.. (1996). Diagnosis of Alzheimer's disease in epidemiologic studies by staged review of clinical data. 9(2). 107–113. 5 indexed citations
19.
Plassman, Brenda L., et al.. (1994). Properties of the telephone interview for cognitive status: Application in epidemiological and longitudinal studies. 7(3). 235–241. 118 indexed citations
20.
Breitner, John C.S.. (1992). Clinical genetics and genetic counseling in Alzheimer's disease. 25(2). 229–246. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Walter A. Kukull Breakdown of academic impact, for papers by Miia Kivipelto Breakdown of academic impact, for papers by Frederick A. Schmitt Breakdown of academic impact, for papers by Nathan Herrmann Breakdown of academic impact, for papers by Oscar L. López Breakdown of academic impact, for papers by Ronald G. Thomas Breakdown of academic impact, for papers by Denis A. Evans Breakdown of academic impact, for papers by David Ames Breakdown of academic impact, for papers by ‌Barry Reisberg Breakdown of academic impact, for papers by Rachelle S. Doody
Rankless by CCL
2026